In this issue:
Results from the JAVELIN BRCA/ATM study
Letrozole and abemaciclib in ER recurrent EC
Chemoradiation and metformin in cervical cancer
The secondary outcome of the PROFAST trial
Bevacizumab vs bevacizumab and erlotinib in patients with Mullerian tumours
HRT treatment for cervical cancer patients
GnRHa and LNG-IUD for women with endometrial cancer
Chemotherapy and radiation therapy in uterine carcinosarcoma
HPV self-sampling among cervical cancer screening
Trabectedin for the treatment of uterine or ovarian carcinosarcoma
Please login below to download this issue (PDF)